Community-led monitoring of HIV and viral hepatitis services: lessons learned and impacts from India and Indonesia

IF 4.9 1区 医学 Q2 IMMUNOLOGY Journal of the International AIDS Society Pub Date : 2024-10-03 DOI:10.1002/jia2.26373
Giten Khwairakpam, Rajkumar Nalinikanta, Caroline Thomas, Solange L. Baptiste, Elise Lankiewicz
{"title":"Community-led monitoring of HIV and viral hepatitis services: lessons learned and impacts from India and Indonesia","authors":"Giten Khwairakpam,&nbsp;Rajkumar Nalinikanta,&nbsp;Caroline Thomas,&nbsp;Solange L. Baptiste,&nbsp;Elise Lankiewicz","doi":"10.1002/jia2.26373","DOIUrl":null,"url":null,"abstract":"<p>Community-led monitoring (CLM) assesses healthcare services and improves health outcomes. It provides insights about the state of local or national HIV responses, assisting managers and policymakers to improve services under the framework of availability, accessibility, acceptability and quality (AAAQ) [<span>1</span>]. Interest in CLM is growing, with support from the International AIDS Society, the Joint United Nations Programme on HIV/AIDS (UNAIDS), the Global Fund to Fight AIDS, TB, and Malaria, and the United States President's Emergency Plan for AIDS Relief (PEPFAR) [<span>2-5</span>].</p><p>The Community-led Monitoring Project in Asia [<span>6</span>] was initiated in 2021 by the Community Network for Empowerment (CoNE) in Manipur, India, Yayasan Peduli Hati Bangsa in Indonesia, the International Treatment Preparedness Coalition—Global (ITPC) and amfAR's TREAT Asia programme. CoNE and Peduli Hati are monitoring 12 health facilities from local districts to referral hospitals that provide public services for HIV and viral hepatitis. CLM indicators are based on national guidelines and policies and target essential components of the AAAQ framework covering HIV, hepatitis B (HBV) and hepatitis C (HCV).</p><p>CLM is a mechanism where care recipients’ perceptions of the essential components of healthcare are captured and leveraged to advocate for changes in service delivery. Our observations indicate that CLM can also play a critical role in addressing urgent individual-level human rights and care access issues in a more rapid timeframe through effective co-problem-solving and advocacy.</p><p>The project is funded by ViiV Healthcare. The authors otherwise have no competing interests to declare.</p><p>GK led the drafting and writing of the manuscript. EL reviewed the draft and final manuscript. RN, CT and SLB provided inputs and edits. All authors approved the final version of the manuscript.</p><p>The CLM in Asia project is supported by ViiV Healthcare and amfAR.</p>","PeriodicalId":201,"journal":{"name":"Journal of the International AIDS Society","volume":"27 10","pages":""},"PeriodicalIF":4.9000,"publicationDate":"2024-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11447636/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the International AIDS Society","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/jia2.26373","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Community-led monitoring (CLM) assesses healthcare services and improves health outcomes. It provides insights about the state of local or national HIV responses, assisting managers and policymakers to improve services under the framework of availability, accessibility, acceptability and quality (AAAQ) [1]. Interest in CLM is growing, with support from the International AIDS Society, the Joint United Nations Programme on HIV/AIDS (UNAIDS), the Global Fund to Fight AIDS, TB, and Malaria, and the United States President's Emergency Plan for AIDS Relief (PEPFAR) [2-5].

The Community-led Monitoring Project in Asia [6] was initiated in 2021 by the Community Network for Empowerment (CoNE) in Manipur, India, Yayasan Peduli Hati Bangsa in Indonesia, the International Treatment Preparedness Coalition—Global (ITPC) and amfAR's TREAT Asia programme. CoNE and Peduli Hati are monitoring 12 health facilities from local districts to referral hospitals that provide public services for HIV and viral hepatitis. CLM indicators are based on national guidelines and policies and target essential components of the AAAQ framework covering HIV, hepatitis B (HBV) and hepatitis C (HCV).

CLM is a mechanism where care recipients’ perceptions of the essential components of healthcare are captured and leveraged to advocate for changes in service delivery. Our observations indicate that CLM can also play a critical role in addressing urgent individual-level human rights and care access issues in a more rapid timeframe through effective co-problem-solving and advocacy.

The project is funded by ViiV Healthcare. The authors otherwise have no competing interests to declare.

GK led the drafting and writing of the manuscript. EL reviewed the draft and final manuscript. RN, CT and SLB provided inputs and edits. All authors approved the final version of the manuscript.

The CLM in Asia project is supported by ViiV Healthcare and amfAR.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
社区主导的艾滋病毒和病毒性肝炎服务监测:印度和印度尼西亚的经验教训和影响。
社区主导的监测(CLM)可评估医疗保健服务并改善医疗成果。它为地方或国家艾滋病毒应对措施的状况提供见解,协助管理者和决策者在可用性、可及性、可接受性和质量(AAAQ)框架下改善服务[1]。在国际艾滋病协会、联合国艾滋病毒/艾滋病联合规划署 (UNAIDS)、全球抗击艾滋病、结核病和疟疾基金以及美国总统艾滋病紧急救援计划 (PEPFAR) 的支持下,人们对社区主导监测的兴趣与日俱增 [2-5]。亚洲社区主导监测项目[6]由印度曼尼普尔的社区赋权网络(CoNE)、印度尼西亚的 Yayasan Peduli Hati Bangsa、全球国际治疗准备联盟(ITPC)和美国艾滋病紧急救援计划的 TREAT 亚洲项目于 2021 年发起。CoNE 和 Peduli Hati 正在对 12 家医疗机构进行监测,这些医疗机构从地方地区到转诊医院都有,为艾滋病毒和病毒性肝炎患者提供公共服务。CLM指标以国家指导方针和政策为基础,针对AAAQ框架中涵盖艾滋病、乙型肝炎(HBV)和丙型肝炎(HCV)的基本组成部分。我们的观察结果表明,通过有效的共同解决问题和宣传,CLM 还能在更快地解决个人层面的紧急人权和医疗服务获取问题方面发挥关键作用。作者没有其他需要声明的利益冲突。EL 审阅了手稿草稿和最终稿。RN、CT 和 SLB 提供了意见和编辑。亚洲 CLM 项目得到了 ViiV Healthcare 和 amfAR 的支持。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of the International AIDS Society
Journal of the International AIDS Society IMMUNOLOGY-INFECTIOUS DISEASES
CiteScore
8.60
自引率
10.00%
发文量
186
审稿时长
>12 weeks
期刊介绍: The Journal of the International AIDS Society (JIAS) is a peer-reviewed and Open Access journal for the generation and dissemination of evidence from a wide range of disciplines: basic and biomedical sciences; behavioural sciences; epidemiology; clinical sciences; health economics and health policy; operations research and implementation sciences; and social sciences and humanities. Submission of HIV research carried out in low- and middle-income countries is strongly encouraged.
期刊最新文献
Comparative effectiveness of dolutegravir + lamivudine versus three-drug regimens in Swedish clinical practice: a nationwide study. Zero discrimination in practice: resisting anti-trans backlash in the global HIV response. The Promise of Integration of HIV Into Primary Care: Challenges and Opportunities. Navigating the Data Gaps of Ageing Among Women Living With HIV. Correction to "What is not measured cannot be improved: the urgency to understand causes of HIV-related deaths in Latin America".
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1